# Subcutaneous Rehydration Compared to Intravenous Rehydration

> **NCT00773175** · PHASE4 · COMPLETED · sponsor: **Halozyme Therapeutics** · enrollment: 148 (actual)

## Conditions studied

- Dehydration

## Interventions

- **DRUG:** recombinant human hyaluronidase

## Key facts

- **NCT ID:** NCT00773175
- **Lead sponsor:** Halozyme Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2018-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773175, "Subcutaneous Rehydration Compared to Intravenous Rehydration". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00773175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*